SOD1 and amyotrophic lateral sclerosis: Tsuburaya et al. screened about 160,000 compounds and identified some low-molecular-weight compounds that inhibit the interaction of 122 SOD1mut and SOD1-Derlin-1, greatly improving the pathology of patient-induced multipotent stem-cell-derived MN and ALS in model mice.